Projecten per jaar
Vingerafdruk
- 1 Soortgelijke profielen
Netwerk
-
ani273: Francqui Leerstoel VUB 2010-2021: appointed to Maria-Luisa Alegre, University of Chicago
1/11/20 → 31/10/22
Project: Fundamenteel
-
OZR3138: Bilaterale samenwerking ikv gemeenschappelijk doctoraatsproject: Bench Fee voor Joint PhD VUB-KUL, Janssens Peter
1/10/16 → 1/10/20
Project: Fundamenteel
Onderzoeksoutput
-
Clinical, Functional, and Mental Health Outcomes in Kidney Transplant Recipients 3 Months After a Diagnosis of COVID-19
ERACODA Collaborators, Duivenvoorden, R., Vart, P., Noordzij, M., Soares Dos Santos, A. C., Zulkarnaev, A. B., Franssen, C. F. M., Kuypers, D., Demir, E., Rahimzadeh, H., Kerschbaum, J., Jager, K. J., Turkmen, K., Hemmelder, M. H., Schouten, M., Rodríguez-Ferrero, M. L., Crespo, M., Gansevoort, R. T., Hilbrands, L. B. & Wissing, K. M., mei 2022, In : Transplantation. 106, 5, blz. 1012-1023 12 blz.Onderzoeksoutput: Article
1 Citaat (Scopus) -
Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EVOCIT Study
François, K., De Clerck, D., Tonnelier, A., Cambier, M-L., Orlando, C., Jochmans, K., Cools, W. & Wissing, K. M., jan 2022, In : American Journal of Kidney Diseases. 79, 1, blz. 79-87.e1 9 blz.Onderzoeksoutput: Article
1 Citaat (Scopus) -
Heparin-grafted dialyzer use is safe in case of Heparin-induced thrombocytopenia
François, K., Orlando, C., Jochmans, K., De Clerck, D., Cambier, M-L., Robberechts, T., Pipeleers, L., Janssens, P. & Wissing, K. M., 1 feb 2022, (Unpublished).Onderzoeksoutput: Poster
-
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?
Wijtvliet, V. P. W. M., Ariën, K. K., Abrams, S., Couttenye, M. M., Mestrez, F., Mariën, J., De Winter, B. Y., Van Damme, P., Pipeleers, L., Wissing, K. M., Abramowicz, D. & Ledeganck, K. J., 1 apr 2022, In : Nephrology Dialysis Transplantation. 37, 4, blz. 799-803 5 blz.Onderzoeksoutput: Article
1 Citaat (Scopus) -
Recovery of dialysis patients with COVID-19: Health outcomes 3 months after diagnosis in ERACODA
ERACODA Collaborators, Hemmelder, M. H., Noordzij, M., Vart, P., Hilbrands, L. B., Jager, K. J., Abrahams, A. C., Arroyo, D., Battaglia, Y., Ekart, R., Mallamaci, F., Malloney, S-R., Oliveira, J., Rydzewski, A., Sridharan, S., Vogt, L., Duivenvoorden, R., Gansevoort, R. T., Franssen, C. F. M. & Wissing, K. M., 14 jan 2022, In : Nephrology Dialysis Transplantation.Onderzoeksoutput: Article
Activiteiten
-
SGLT2 inhibitoren: Doorbraak in de preventie en behandeling van hartfalen en chronische nieraandoeningen
Karl Martin Wissing (Speaker)30 sep 2021Activiteit: Talk or presentation at a workshop/seminar
-
Outcome of SARS-CoV-2 virus-infected organ transplant recipients - results of the BECOVSOT registry
Karl Martin Wissing (Speaker)16 sep 2021Activiteit: Talk or presentation at a conference
-
CaRe4Me - CardioRenalMetabolics/Astra Zeneca
Peter Janssens (Participant), Karl Martin Wissing (Organiser)30 sep 2021Activiteit: Participation in conference
-
International Francqui-Collen Chair 2021
Karl Martin Wissing (Organiser)18 mrt 2021 → 7 okt 2021Activiteit: Participating in or organizing a public lecture/debate
-
BTS Webinar "Innovative therapies of EBV-associated PTLD"
Karl Martin Wissing (Organiser), Daniel Jacobs-Tulleneers-Thevissen (Organiser)21 mrt 2021Activiteit: Participation in workshop, seminar
Scriptie
-
A pilot study on the use of nocturnal natriuresis and random spot urine versus 24h natriuresis to assess dietary compliance and the efficacy of dietary intervention on salt consumption (and blood pressure) in patients with chronic kidney disease and therapy resistant hypertension
Auteur: Boesmans, S., Wissing, K. M. & Van der Niepen, P., 22 jun 2012Scriptie/masterproef: Master's Thesis
-
Efficacy of Thrombolysis with Urokinase Containing Locking Solutions for Thrombotic Dysfunction of Tunneled Hemodialysis Catheters: a Retrospective Single-Centre Cohort Study
Auteur: Van Hulle, F. O., 2015Begeleider: Bonkain, F. (Promotor) & Wissing, K. M. (Promotor)
Scriptie/masterproef: Master's Thesis
-
Experimental FSGS: pathology and therapeutic approach
Auteur: Van Beneden, K., Van Den Branden, C., van Grunsven, L. A., Thielemans, K., Wissing, K. M., Florquin, S., van der Vlag, J. & Le Moine, A., 21 jun 2012Begeleider: Van Den Branden, C. (Promotor), Van Grunsven, L. A. (Promotor), Thielemans, K. (Jury), Vanderkerken, K. (Jury), Wissing, K. M. (Jury), Florquin, S. (Externe persoon) (Jury), van der Vlag, J. (Externe persoon) (Jury) & Le Moine, A. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis
-
HLA epitope based mismatching with HLA-Matchmaker: a retrospective study of the effect of epitope mismatching on the incidence of acutre rejection and the occurance of de novo anti-HLA antibodies in a Belgian single center
Auteur: Thielemans, N., 2016Begeleider: Wissing, K. M. (Promotor), Pipeleers, L. (Co-promotor) & Verheyden, S. (Co-promotor)
Scriptie/masterproef: Master's Thesis
-
Immune monitoring in type 1 diabetic recipients of defined beta cell grafts: contribution to assess clinical outcome
Auteur: Hilbrands, R., Keymeulen, B., Pipeleers, D., Van Schravendijk, C., Thielemans, K., Velkeniers-Hoebanckx, B., Wissing, K. M., Piemonti, L. & Plum, J., 9 mei 2012Begeleider: Keymeulen, B. (Promotor), Pipeleers, D. (Promotor), Van Schravendijk, C. (Jury), Thielemans, K. (Jury), Velkeniers, B. (Externe persoon) (Jury), Wissing, K. M. (Jury), PIEMONTI, L. (Externe persoon) (Jury) & Plum, J. (Externe persoon) (Jury)
Scriptie/masterproef: Doctoral Thesis